팬젠 둜고

팬젠 (222110) μ£Όκ°€ 및 μ’…λͺ© 정보

팬젠 μ‹€μ‹œκ°„ μ£Όκ°€

ν˜„μž¬κ°€ 5,020 원
λ³€λ™λŸ‰ β–² 70.00 원
변동λ₯  1.41%
κ±°λž˜λŸ‰ 37,776
κ±°λž˜λŒ€κΈˆ 193,309,456 원

팬젠 일별 μ£Όκ°€

팬젠의 κ³Όκ±° 일별 μ£Όκ°€
λ‚ μ§œ μ‹œκ°€ κ³ κ°€ μ €κ°€ μ’…κ°€ κ±°λž˜λŸ‰ κ±°λž˜λŒ€κΈˆ
4/2/2025 4,560 4,680 4,400 4,630 9,981 45,162,940
4/3/2025 4,540 4,710 4,400 4,710 12,034 55,377,235
4/6/2025 4,580 4,595 4,360 4,380 15,766 70,434,445
4/7/2025 4,385 4,600 4,305 4,505 25,983 115,850,510
4/8/2025 4,550 4,635 4,445 4,520 10,610 48,010,885
4/9/2025 4,530 4,770 4,530 4,690 39,766 187,654,615
4/10/2025 4,690 4,925 4,540 4,875 30,279 142,975,676
4/13/2025 4,900 5,000 4,820 5,000 8,956 44,102,340
4/14/2025 5,000 5,020 4,860 4,950 11,546 56,709,620
4/15/2025 4,935 5,380 4,895 5,020 37,776 193,309,456

κ΄€λ ¨ ν…Œλ§ˆ

  • λ°”μ΄μ˜€μ‹œλ°€λŸ¬ : λ°”μ΄μ˜€μ‹œλ°€λŸ¬ μ˜μ•½ν’ˆ 개발, 제쑰 μ—…μ²΄λ‘œ λ°”μ΄μ˜€μ‹œλ°€λŸ¬ μ˜μ•½ν’ˆμ€ EPO(빈혈 치료제), Factor VIII(ν˜ˆμš°λ³‘A 치료제) 및 G-CSF(ν•­μ•”μΉ˜λ£Œ 보쑰제) μ œν’ˆμ„ 순차적으둜 개발 쀑
  • 혈μž₯치료 : ν˜ˆμš°λ³‘ μΉ˜λ£Œμ œμ™€ λ‹€μ–‘ν•œ ν˜ˆμ•‘ κ΄€λ ¨ 치료제λ₯Ό κ°œλ°œν•΄ 혈μž₯ 치료 관련주에 νŽΈμž…

팬젠 νšŒμ‚¬ 정보

μ‹œμž₯ μ‹œκ°€μ΄μ•‘ κΈ°μ—…μˆœμœ„ μ£Όμ‹μˆ˜ 외ꡭ인 비쀑 μ‚°μ—…κ΅° μ„ΈλΆ€ μ‚°μ—…κ΅° 52μ£Ό 졜고 52μ£Ό μ΅œμ €
kosdaq 647μ–΅ 1063μœ„ 12,898,197 7.71% ν—¬μŠ€μΌ€μ–΄ 생λͺ…κ³Όν•™/곡학 7,770 3,750

팬젠 κΈ°μ—… κ°œμš”

νŒ¬μ  μ€ 2010λ…„ 1μ›” μ„€λ¦½λœ κΈ°μ—…μœΌλ‘œ λ°”μ΄μ˜€μ‹œλ°€λŸ¬ EPO μ˜μ•½ν’ˆμ˜ 생산 및 판맀, λ°”μ΄μ˜€μ˜μ•½ν’ˆ 개발, λ°”μ΄μ˜€μ˜μ•½ν’ˆ μœ„νƒμƒμ‚° 및 개발기술 μ΄μ „μ„œλΉ„μŠ€ λ“±μ˜ 사업을 μ˜μœ„ν•˜κ³  μžˆλ‹€. μ£Όμš” λ§€μΆœμ€ EPO μ˜μ•½ν’ˆ νŒλ§€μ—μ„œ λ°œμƒν•˜κ³  μžˆλ‹€. λ‹Ήμ‚¬λŠ” λ§Œμ„± μ‹ λΆ€μ „ ν™˜μžμ˜ 빈혈 치료제인 λ°”μ΄μ˜€μ‹œλ°€λŸ¬ EPO μ˜μ•½ν’ˆ 자체 μ œν’ˆκ°œλ°œμ— μ„±κ³΅ν•˜μ—¬ κ΅­λ‚΄ 및 λ§λ ˆμ΄μ‹œμ•„ μ‹œμž₯μ—μ„œ 판맀 쀑에 있으며 κ·Έ 밖에 λ‹€μ–‘ν•œ λ°”μ΄μ˜€ μ˜μ•½ν’ˆμ„ 개발 쀑에 μžˆλ‹€.

팬젠 맀좜 정보

λ‚ μ§œ λ§€μΆœμ•‘ λ§€μΆœμ•‘ μ¦κ°€μœ¨ μ˜μ—…μ΄μ΅ μ˜μ—…μ΄μ΅ μ¦κ°€μœ¨ 순이읡 순이읡 μ¦κ°€μœ¨
2024.4Q 14,672,686,810 - 1,020,165,959 - 943,686,868 -
2023.4Q 7,315,125,370 12.53% -4,225,497,054 7.95% -4,488,830,770 0.11%
2022.4Q 6,500,658,000 -18.08% -4,590,629,400 -39.60% -4,493,832,000 -35.75%
2021.4Q 7,935,565,000 28.18% -3,288,356,900 11.13% -3,310,318,300 24.01%

팬젠 νˆ¬μžμžλ³„ 맀맀동ν–₯

μˆœλ§€μˆ˜λŸ‰

개인: 9,684

κΈ°κ΄€: -943

외인: -8,741

λˆ„μ  μˆœλ§€μˆ˜λŸ‰

개인: 91,377

κΈ°κ΄€: -40,412

외인: -50,965

순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2025-04-16 9,684 -943 -8,741
2025-04-15 805 - -805
2025-04-14 -468 - 468
2025-04-11 -4,919 -306 5,225
2025-04-10 27,614 -27,647 33
2025-04-09 -1,446 -160 1,606
2025-04-08 -8,112 -320 8,432
2025-04-07 2,064 - -2,064
2025-04-04 -959 - 959
2025-04-03 -2,983 - 2,983
2025-04-02 9,541 -4,756 -4,785
2025-04-01 2,048 -4,256 2,208
2025-03-31 1,843 -2 -1,841
2025-03-28 898 499 -1,397
2025-03-27 67 40 -107
2025-03-26 950 - -950
2025-03-25 -1,881 -37 1,918
2025-03-24 2,623 -7,836 5,213
2025-03-21 -3,833 - 3,833
2025-03-20 -1,345 - 1,345
2025-03-19 -7,119 - 7,119

λˆ„μ  순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2025-04-16 25,072 -45,724 20,652
2025-04-15 15,388 -44,781 29,393
2025-04-14 14,583 -44,781 30,198
2025-04-11 15,051 -44,781 29,730
2025-04-10 19,970 -44,475 24,505
2025-04-09 -7,644 -16,828 24,472
2025-04-08 -6,198 -16,668 22,866
2025-04-07 1,914 -16,348 14,434
2025-04-04 -150 -16,348 16,498
2025-04-03 809 -16,348 15,539
2025-04-02 3,792 -16,348 12,556
2025-04-01 -5,749 -11,592 17,341
2025-03-31 -7,797 -7,336 15,133
2025-03-28 -9,640 -7,334 16,974
2025-03-27 -10,538 -7,833 18,371
2025-03-26 -10,605 -7,873 18,478
2025-03-25 -11,555 -7,873 19,428
2025-03-24 -9,674 -7,836 17,510
2025-03-21 -12,297 - 12,297
2025-03-20 -8,464 - 8,464
2025-03-19 -7,119 - 7,119

팬젠 μžμ‚° λΉ„μœ¨

μžμ‚°μ΄κ³„ λΆ€μ±„λΉ„μœ¨ μžλ³ΈλΉ„μœ¨
30,544,682,369 18.45% 81.55%

팬젠 맀좜 ꡬ성

ꡬ성 μš”μ†Œ λΉ„μœ¨
λ°”μ΄μ˜€μ‹œλ°€λŸ¬ EPO [EPOμ˜μ•½ν’ˆ] 46.6%
μœ„νƒμƒμ‚°(CMO) 21.8%
기타 13.3%
κΈ°μˆ μ΄μ „(CDO) 13.2%
λ‘œμ—΄ν‹° 3.7%
μƒν’ˆ 1.4%

팬젠 곡맀도 ν˜„ν™©

졜근 곡맀도 κ±°λž˜λŸ‰: 28 (0.07%)

졜근 곡맀도 μž”κ³ : 0 (0%)

곡맀도 κ±°λž˜λŸ‰

λ‚ μ§œ μ’…κ°€ κ³΅λ§€λ„λŸ‰ 곡맀도비쀑
2025-04-16 5,020 28 0.07%
2025-04-15 4,950 34 0.29%
2025-04-14 5,000 0 0.00%
2025-04-11 4,875 0 0.00%
2025-04-10 4,690 0 0.00%
2025-04-09 4,520 0 0.00%
2025-04-08 4,505 0 0.00%
2025-04-07 4,380 903 5.73%
2025-04-04 4,710 118 0.98%
2025-04-03 4,630 433 4.34%
2025-04-02 4,590 0 0.00%
2025-04-01 4,610 0 0.00%
2025-03-31 4,630 0 0.00%
2025-03-28 4,780 0 0.00%
2025-03-27 4,930 0 0.00%
2025-03-26 5,020 0 0.00%
2025-03-25 5,060 0 0.00%
2025-03-24 5,030 0 0.00%
2025-03-21 4,945 0 0.00%
2025-03-20 4,990 0 0.00%
2025-03-19 5,000 0 0.00%

곡맀도 μž”κ³ 

λ‚ μ§œ μ’…κ°€ 곡맀도 μž”κ³  곡맀도 비쀑
2025-04-14 5,000 0 0.00%
2025-04-11 4,875 0 0.00%
2025-04-10 4,690 0 0.00%
2025-04-09 4,520 0 0.00%
2025-04-08 4,505 0 0.00%
2025-04-07 4,380 0 0.00%
2025-04-04 4,710 0 0.00%
2025-04-03 4,630 0 0.00%
2025-04-02 4,590 0 0.00%
2025-04-01 4,610 0 0.00%
2025-03-31 4,630 0 0.00%
2025-03-28 4,780 0 0.00%
2025-03-27 4,930 0 0.00%
2025-03-26 5,020 0 0.00%
2025-03-25 5,060 0 0.00%
2025-03-24 5,030 0 0.00%
2025-03-21 4,945 0 0.00%
2025-03-20 4,990 0 0.00%
2025-03-19 5,000 0 0.00%
2025-03-18 4,930 0 0.00%
2025-03-17 4,995 0 0.00%

팬젠 μ—…μ’… λ‚΄ 비ꡐ

생λͺ…κ³Όν•™/곡학 μ—…μ’…(90개) μ—°κ°„ κΈ°μ€€

ν•­λͺ© 팬젠 μ—…μ’… 평균 μ—…μ’… λ‚΄ μˆœμœ„
μ‹œκ°€μ΄μ•‘ 638.461 7,238.69 70μœ„
PER(졜근4λΆ„κΈ°) - - -μœ„
PBR 3.136 9.07 41μœ„
ROE(졜근4λΆ„κΈ°) -30.141 -46.75 45μœ„
λ°°λ‹Ήμˆ˜μ΅λ₯ (μ΅œκ·Όμ—°λ„) - - -μœ„
μ˜μ—…μ΄μ΅λ₯ (μ΅œκ·Όμ—°λ„) 6.953 -2,166.91 13μœ„
순이읡λ₯ (μ΅œκ·Όμ—°λ„) 6.432 -2,119.65 17μœ„
λΆ€μ±„λΉ„μœ¨(μ΅œκ·Όμ—°λ„) 22.626 81.92 63μœ„
λ§€μΆœμ•‘(μ΅œκ·Όμ—°λ„) 146.727 477.57 33μœ„
μ˜μ—…μ΄μ΅(μ΅œκ·Όμ—°λ„) 10.202 -85.98 16μœ„
λ‹ΉκΈ°μˆœμ΄μ΅(μ΅œκ·Όμ—°λ„) 9.437 -72.57 22μœ„